Results 81 to 90 of about 114,130 (205)

Oncological Outcomes and Safety Profiles of Adjuvant Nivolumab in Muscle‐Invasive Urothelial Carcinoma

International Journal of Urology, Volume 33, Issue 10, October 2026.
ABSTRACT Objectives Perioperative immunotherapy has become the standard of care in patients with high‐risk muscle‐invasive urothelial carcinoma (MIUC). This study aimed to clarify oncological outcomes and safety profiles of adjuvant nivolumab therapy in MIUC, focusing on upper tract urothelial carcinoma (UTUC).
Satoshi Katayama, Tatsushi Kawada, Keiichiro Mori, Kosuke Iwatani, Shota Inoue, Tomofumi Watanabe, Ichiro Tsuboi, Tomoaki Yamanoi, Takehiro Iwata, Kazuma Tsuboi, Wataru Murao, Tetsuya Nakada, Kohei Ogawa, Akihiro Matsukawa, Takafumi Yanagisawa, Shingo Nishimura, Kensuke Bekku, Koichiro Wada, Takahiro Kimura, Motoo Araki   +19 more
wiley   +1 more source

Spontaneous Hepatobiliary Disease in a Breeding Colony of Aotus spp.

Journal of Medical Primatology, Volume 55, Issue 5, October 2026.
ABSTRACT Background Owl monkeys are nonhuman primate species in the genus Aotus. The Michale E. Keeling Center for Comparative Medicine and Research maintains an Owl Monkey Breeding and Research Resource composed of four species of owl monkeys: Aotus nancymai, A. vociferans, A. azarae, and A. griseimembra.
M. E. Hensel, G. W. Wilkerson, L. Yan, C. L. Hodo, S. M. Kezar   +4 more
wiley   +1 more source

Establishment of a humanized patient‐derived xenograft mouse model of high‐grade serous ovarian cancer for preclinical evaluation of combination immunotherapy

Molecular Oncology, Volume 20, Issue 9, Page 2203-2219, September 2026.
We have established a humanized orthotopic patient‐derived xenograft (Hu‐oPDX) mouse model of high‐grade serous ovarian cancer (HGSOC) that recapitulates human tumor–immune interactions. Using combined anti‐PD‐L1/anti‐CD73 immunotherapy, we demonstrate the model's improved biological relevance and enhanced translational value for preclinical ...
Luka Tandaric, Line Bjørge, Martine Rott Lode, Cecilie Fredvik Torkildsen, Pia Aehnlich, Rammah Elnour, Daniela Elena Costea, Lars Andreas Akslen, Liv Cecilie Vestrheim Thomsen, Emmet McCormack, Katrin Kleinmanns   +10 more
wiley   +1 more source

Surgical strategies for gastric cancer with synchronous peritoneal carcinomatosis

, 2006
BACKGROUND: Gastric cancer frequently spreads to the peritoneal cavity. Whether laparoscopy is useful in planning therapy remains controversial. The aim of this study was to investigate the value of laparoscopy and to develop a therapeutic algorithm ...
Estevez-Schwarz, L., Schneider, U., Schlag, P.M., Siegel, R., Huenerbein, M., Gretschel, S.   +5 more
core   +1 more source

Non-Coding RNAs in Peritoneal Carcinomatosis: From Bench to Bedside [PDF]

Peritoneal carcinomatosis represents an advanced stage of tumors within the peritoneal cavity. Once considered an incurable terminal cancer metastasis, contemporary medicine is on the hunt for certain potentially curative options alongside the present ...
Calin, George A, George A. Calin, Slaby, Ondrej, Julia Bohosova, Nida Sarosh Ashraf, Ondrej Slaby, Ashraf, Nida Sarosh, Bohosova, Julia   +7 more
core   +1 more source

Peritoneal sarcoidosis: an unusual presentation and a brief review of the literature

Monaldi Archives for Chest Disease, 2015
Peritoneal involvement continues to be a rare manifestation of sarcoidosis: its involvement is not always isolated and sarcoid granulomas are also found elsewhere. Peritoneal diseases tend to have an increased incidence in women.
A. Nicolini, M. Vita, S. Lanata
doaj   +1 more source

MODERN STRATEGY IN TREATMENT OF PERITONEAL CARCINOMATOSIS [PDF]

, 2017
Peritoneal carcinomatosis (PC) is a common manifestation of progression in peritoneal and gynecologic malignancies. Current primary strategy in treatment of PC is the concept of regional influence by the way of cytoreductive surgery and intraperitoneal ...
A. S. Natkha, V. A. Rybalchenko, O. A. Ten, A. A. Trushin, K. N. Vovin, A. A. Zakharenko, D. A. Zaitcev, M. A. Belyaev   +7 more
core   +1 more source

An Unusual Case of Peritoneal Carcinomatosis

Case Reports in Oncology, 2010
The peritoneal surface remains an important failure site for patients with gastrointestinal and gynecologic malignancies. In the past, oncologists regarded peritoneal carcinomatosis as an incurable component of an intra-abdominal malignancy.
Stijn Hillewaere, Linde Stessens, Kurt Van der Speeten   +2 more
doaj   +1 more source

Fluorescent Nanoparticles for the Guided Surgery of Ovarian Peritoneal Carcinomatosis

, 2018
International audienceComplete surgical resection is the ideal cure for ovarian peritoneal carcinomatosis, but remains challenging. Fluorescent guided surgery can be a promising approach for precise cytoreduction when appropriate fluorophore is used.
Marchal, Frédéric, Pons, Thomas, Sophie Marchal, Tristan Mangeolle, Marchal, Sophie, Simon, Lina Bezdetnaya, Thomas Pons, Mangeolle, Tristan, Ilya Yakavets, Yakavets, Ilya, Frédéric Marchal, Debayle, Manon, Bezdetnaya, Lina, Manon Debayle, Mangeolle, T., Yakavets, I., Marchal, S., Bezdetnaya, L., Marchal, F., Debayle, M., Pons, T.   +20 more
core   +1 more source

The trifunctional antibody catumaxomab in treatment of malignant ascites and peritoneal carcinomatosis

, 2010
Peritoneal carcinomatosis remains an unsolved medical problem in modern oncologic treatment. Excruciating symptoms such as malignant ascites, ileus, nausea, vomiting, dyspnoea and pain deteriorate the quality of life for affected patients.
Michael A Ströhlein, Markus M Heiss
core   +1 more source